Another way to encourage tumor-specific selectivity is by using multifunctional NPs that work through cooperativity in binding to more than one (usually dual targeting) overexpressed cancer cell surface receptor to overcome the issue of low-level expression of the same markers by off-target cells, which results in nonspecific NP delivery and toxicity [166]. The gene discussed is CD177; the disease is neoplasm.